| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d196f21c80dd433e5096e90db809caad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5a3154cbd481cdc98a1e5dc1ee0ab98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8778713427f3c00296d87dcb061a063e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_55daaf3f7bfc0025f918c419769f95f9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-24 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate |
2012-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca6e2c331e6e0cb7dd0132347362a189
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9856229c4343c5137ec3cc6a2c284833
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_304eb97cea7d07ae4cf98acde0fae46c |
| publicationDate |
2014-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2014018018-A1 |
| titleOfInvention |
Composition and method for reducing tissue damage from inflammatory disorder or pathogenic infection |
| abstract |
Compositions and methods for preventing or ameliorating tissue damage caused by an inflammatory disorder or pathogenic infections are described. In one aspect, a method for preventing or ameliorating tissue damage caused by an inflammatory disorder or pathogenic infection comprises administering to a subject a therapeutically effective amount of a neuregulin, wherein said neuregulin is administered in a dosage range from about 0.01 mg/kg body weight/day to about 1000 mg/kg body weight/day. In another aspect, the composition comprises one or more active agents that: (a) increase expression or activity of a neuregulin; (b) inhibit the expression or activity of CXCL1O, STAT3 or HEME; or (c) both (a) and (b). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017087825-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108883150-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105572385-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017075053-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023070078-A1 |
| priorityDate |
2012-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |